Development and psychometric evaluation of the self-assessment of psoriasis symptoms (SAPS) – clinical trial and the SAPS – real world patient-reported outcomes

Development and psychometric evaluation of the self-assessment of psoriasis symptoms (SAPS) – clinical trial and the SAPS – real world patient-reported outcomes

Objective: The Self-Assessment of Psoriasis Symptoms – Clinical Trials (SAPS-CT) and SAPS – Real World (SAPS-RW) were simultaneously created to assess the experience of plaque psoriasis in two unique contexts. Methods: Qualitative and quantitative research was conducted in four phases namely concept...

Full description

Bibliographic Details
Main Authors:	April W. Armstrong, Benjamin Banderas, Catherine Foley, Jonathan Stokes, Murali Sundaram, Alan L. Shields
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2017-08-01
Series:	Journal of Dermatological Treatment
Subjects:	pro chronic plaque psoriasis instrument context of use qualitative psychometric
Online Access:	http://dx.doi.org/10.1080/09546634.2017.1290206

Similar Items

The content validity of the PSS in patients with plaque psoriasis
by: A. M. Rentz, et al.
Published: (2017-09-01)

Development and initial psychometric evaluation of patient-reported outcome questionnaires to evaluate the symptoms and impact of hidradenitis suppurativa
by: Alexa B. Kimball, et al.
Published: (2018-02-01)

Development and Content Validation of the Psoriasis Symptoms and Impacts Measure (P-SIM) for Assessment of Plaque Psoriasis
by: Alice B. Gottlieb, et al.
Published: (2020-08-01)

Reliability, validity, and the ability to detect change of the Psoriasis Symptom Scale (PSS) in patients with plaque psoriasis
by: Anne M. Rentz, et al.
Published: (2020-07-01)

Childhood psoriasis: What is new and what is news
by: Sunil Dogra, et al.
Published: (2018-01-01)

Cost-effectiveness of tildrakizumab for the treatment of moderate-to-severe psoriasis in the United States
by: Xiaoying Jia, et al.
Published: (2022-02-01)

Association of Streptococcus with Plaque Type of Psoriasis
by: Mohammad Akram Hossain, et al.
Published: (2015-05-01)

Treating pediatric plaque psoriasis: challenges and solutions
by: Thomas J, et al.
Published: (2016-04-01)

A Comprehensive Review of Ixekizumab Efficacy in Nail Psoriasis from Clinical Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis
by: Bruce W. Kirkham, et al.
Published: (2023-07-01)

Secukinumab retreatment associated psoriasis flare with pustules
by: Mohamed EL-Komy, et al.
Published: (2022-02-01)

Matching-Adjusted Indirect Comparison of the Long-Term Efficacy of Deucravacitinib Versus Adalimumab for Moderate to Severe Plaque Psoriasis
by: April W. Armstrong, et al.
Published: (2023-07-01)

A real-world study to assess the effectiveness of itolizumab in patients with chronic plaque psoriasis
by: Anchala Parthasaradhi, et al.
Published: (2017-01-01)

Risankizumab for Plaque and Guttate Psoriasis in a Patient With IgA-Related Glomerulonephritis
by: Annunziata Dattola, et al.
Published: (2021-10-01)

Evaluation of the Demographic and Clinical Data of Psoriasis Patients: A Detailed Analysis of a Big Series
by: Tugba Ozkok Akbulut, et al.
Published: (2022-01-01)

Clinical efficacy and safety of secukinumab in patients with psoriasis and comorbidities: pooled analysis of 4 phase 3 clinical trials
by: Alice B. Gottlieb, et al.
Published: (2022-04-01)

New possibilities of systemic therapy of plaque psoriasis with the IL23p19 inhibitor risankizumab
by: O. V. Zhukova, et al.
Published: (2021-06-01)

Topographic Differential Diagnosis of Chronic Plaque Psoriasis: Challenges and Tricks
by: Paolo Gisondi, et al.
Published: (2020-11-01)

Single-plaque psoriasis: a single-clue diagnostic challenge
by: Decean Luminita Emilia, et al.
Published: (2022-09-01)

Evaluation of intralesional 5% 5-fluorouracil in resistant localized plaque psoriasis
by: Bharat Bhushan Mahajan, et al.
Published: (2014-01-01)

Histone Deacetylase 1 and Sirtuin 1 Expression in Psoriatic Skin: A Comparison between Guttate and Plaque Psoriasis
by: Young-Ji Hwang, et al.
Published: (2020-08-01)

Development and psychometric evaluation of a new patient -reported outcome measure for psoriasis self-management efficacy: the self-management efficacy questionnaire among patients with psoriasis (SMEQ-PSO)
by: Yuanhui Sun, et al.
Published: (2023-06-01)

The Potential Benefits of Certolizumab Pegol in Patients with Concurrent Psoriatic Arthritis and Chronic Plaque Psoriasis: A Case Series and Review of the Literature
by: David Rutkowski, et al.
Published: (2019-03-01)

Secukinumab in the Treatment of Plaque Psoriasis in Patients with Malignancy
by: Alessio Gambardella
Published: (2019-09-01)

Secukinumab for plaque psoriasis
by: Gonzalo Ordenes-Cavieres, et al.
Published: (2018-11-01)

Evaluation of therapeutic response of methotrexate and calcipotriol combination compared with methotrexate alone in plaque psoriasis
by: Deepthi Vasanthada, et al.
Published: (2014-04-01)

Management of Plaque Psoriasis: A Review and Comparison of IL-23 Inhibitors
by: Nicole L. Bolick, et al.
Published: (2020-12-01)

Subgingival microbiota and periodontal clinical status in patients with plaque psoriasis: A cross-sectional study
by: Grissel Orozco-Molina, et al.
Published: (2023-01-01)

New Onset of Severe Plaque Psoriasis Following COVID-19 Vaccination: A Case Report
by: Hu YQ, et al.
Published: (2022-08-01)

Development of the Psoriasis Symptoms Scale (PSS) in patients with moderate-to-severe psoriasis: qualitative and quantitative analyses
by: April W. Armstrong, et al.
Published: (2020-07-01)

Treatment of moderate-to-severe plaque psoriasis with tildrakizumab in the real-life setting
by: Martina Burlando, et al.
Published: (2021-05-01)

Microbiota differences of skin and pharyngeal microbiota between patients with plaque and guttate psoriasis in China
by: Jingjin Hu, et al.
Published: (2022-08-01)

Reliability and validity of the Psoriasis Itch Visual Analog Scale in psoriasis vulgaris
by: Claus Bang Pedersen, et al.
Published: (2017-04-01)

Validation of psychometric properties and development of response criteria for the psoriasis symptoms and signs diary (PSSD): results from a phase 3 clinical trial
by: April Armstrong, et al.
Published: (2019-01-01)

Development of a patient-reported outcome questionnaire for use in adults with moderate-to-severe plaque psoriasis: The Psoriasis Symptoms and Signs Diary
by: Steven R. Feldman, et al.
Published: (2016-01-01)

Comorbidities and Medication Use in Finnish Patients with Psoriasis: A Population-Based Registry Study
by: Aino Vesikansa, et al.
Published: (2023-03-01)

Psychometric evaluation of the Indolent Systemic Mastocytosis Symptom Assessment Form (ISM-SAF©) and determination of a threshold score for moderate symptoms
by: Alan L. Shields, et al.
Published: (2023-03-01)

Myeloperoxidase Inhibition Ameliorates Plaque Psoriasis in Mice
by: Savannah D. Neu, et al.
Published: (2021-08-01)

Association between antistreptolysin-O serum level and chronic plaque psoriasis in Iraqi patients
by: Abeer T Al-Hassnawi, et al.
Published: (2016-01-01)

Summary of Research: Switching Between Adalimumab Reference Product and BI 695501 in Patients with Chronic Plaque Psoriasis (VOLTAIRE-X): A Randomized Controlled Trial
by: Alan Menter
Published: (2023-10-01)

Brodalumab Versus Guselkumab in Patients with Moderate-to-Severe Psoriasis with an Inadequate Response to Ustekinumab: A Randomized, Multicenter, Double-Blind Phase 4 Trial (COBRA)
by: Kristian Reich, et al.
Published: (2024-02-01)